Fairchem Organics reported a net profit of ₹100 crore for the quarter ended June 30, 2026, marking a 751% year-on-year increase from ₹12 crore in the corresponding period of the previous fiscal. The specialty chemicals manufacturer achieved this turnaround primarily through improved price realization in the domestic market, supported by lower import competition due to supply chain constraints. Revenue from operations climbed 34.4% to ₹1,761 crore, while EBITDA nearly tripled to ₹179 crore, signaling strong operational momentum in the first quarter of FY27.

The Board of Directors approved the unaudited financial results on July 27, 2026, pursuant to Regulation 30 read with Schedule III Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were prepared in accordance with Ind AS and reviewed by the Audit Committee before board approval. Statutory Auditors KPMG expressed an unmodified review conclusion on the limited review of the financial statements, having audited the company for the last nine years.

Financial Performance Highlights

The company's total income reached ₹1,764 crore in Q1FY27, up from ₹1,312 crore in Q1FY26. This growth was fueled by higher revenue from operations, which stood at ₹1,761 crore against ₹1,311 crore in the prior year period. Other income contributed marginally at ₹3 crore. The following table summarises the key financial metrics for the quarter:

*Note: EPS figures derived from reported PAT and equity shares outstanding; previous year EPS adjusted for comparability.

Cost of materials consumed rose to reflect increased production volumes, while finance costs nearly doubled to ₹18 crore from ₹10 crore. Despite these cost increases, the company managed to expand its pre-tax profit significantly to ₹136 crore from ₹16 crore in the prior year period. Total expenses grew at a slower pace of 25.8% compared to revenue growth of 34.4%, demonstrating operating leverage.

Strategic Outlook and Market Position

Operating in a single reportable segment of specialty chemicals, including oleo chemicals and intermediate nutraceuticals, Fairchem Organics generated segment revenue of ₹1,761 crore. Segment assets grew to ₹397.52 crore as of June 30, 2026, from ₹361.90 crore a year earlier. The company maintains a competitive advantage through its "waste-to-wealth" manufacturing model, processing by-products like Acid Oil and Deodorizer Distillate from vegetable oil refineries into high-value chemicals such as Isostearic Acid and Dimer Acid.

Management highlighted four key strategies for future growth: cost optimization through energy audits and domestic catalyst substitution, product upgradation including low-titre Linoleic Acid, new product development such as bypass fat from PFAD, and geographical diversification. With level-playing tariffs in the US and proposed Free Trade Agreements with the EU and UK, the company aims to increase exports initially by 25% and eventually to 50% of sales.

What the Numbers Show

The dramatic turnaround in profitability is evident across multiple metrics. While revenue growth of 34% is substantial, the EBITDA margin expansion from 3.97% to 10.16% highlights a meaningful improvement in operating efficiency. The 744% surge in pre-tax profit further indicates significant operating leverage, as the company successfully converted top-line growth into bottom-line gains despite rising material and finance costs. This performance underscores the resilience of the specialty chemicals business model during this period, leveraging its position as one of the lowest-cost producers globally due to secure, low-cost raw material supply chains.

Fairchem Organics Limited shareholders overwhelmingly approved a final dividend of Re. 1.00 per equity share and the re-appointment of key board members at its 7th Annual General Meeting (AGM) held on July 27, 2026. The meeting, conducted via Video Conferencing/Other Audio Visual Means (OAVM), saw high participation with 49 shareholders casting votes on all resolutions, reflecting strong engagement from the investor base. The dividend declaration for the financial year ended March 31, 2026, received near-unanimous support, while the re-appointment of Managing Director Nahoosh Jariwala and Independent Director Sudhin Choksey also secured overwhelming assent.

The scrutinizer’s report, submitted by Uday Dave of Parikh Dave & Associates, confirmed that all six resolutions placed before the members were passed. The results were filed with the stock exchanges pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Voting rights were reckoned as on July 20, 2026, with remote e-voting open from July 22 to July 26, followed by e-voting during the AGM.

Voting Results Breakdown

The consolidated results for each resolution are detailed below:

Key Appointments and Governance

The special resolutions included the re-appointment of Nahoosh Jariwala as Managing Director for a further period of three years, effective August 13, 2026, to August 12, 2029. This resolution received nearly unanimous support, with only 56 dissenting votes out of over 89 lakh total votes cast. Similarly, the re-appointment of Sudhin Choksey as an Independent Director for a second term of five years, effective February 11, 2027, was approved with 96.92% support.

Sumit Maheshwari, who retires by rotation, was re-appointed as a Director under an ordinary resolution. While this resolution passed with 96.93% support, it recorded higher dissent compared to other items, with 2,75,056 votes cast against it. The adoption of the audited financial statements for FY26 and the ratification of remuneration payable to Cost Auditors for FY27 also received full support from the voting shareholders.

What the Numbers Show

The voting pattern indicates strong shareholder confidence in the company’s leadership and financial reporting. The negligible dissent on the dividend declaration and the MD’s re-appointment suggests alignment between management strategy and shareholder interests. The slightly higher dissent on the re-appointments of Sumit Maheshwari and Sudhin Choksey, though still resulting in approval, may reflect active engagement from a segment of the investor base regarding board composition, although the overall outcome remains decisive in favor of management proposals.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0DNW01011/2556b43825c94626.pdf